|
1
|
Günther T, Tulipano G, Dournaud P,
Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño
JP, Wester HJ, et al: International union of basic and clinical
pharmacology. CV. Somatostatin receptors: Structure, function,
ligands, and new nomenclature. Pharmacol Rev. 70:763–835. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Day R, Dong W, Panetta R, Kraicer J,
Greenwood MT and Patel YC: Expression of mRNA for somatostatin
receptor (sstr) types 2 and 5 in individual rat pituitary cells. A
double labeling in situ hybridization analysis. Endocrinology.
136:5232–5235. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Florio T: Somatostatin/somatostatin
receptor signalling: Phosphotyrosine phosphatases. Mol Cell
Endocrinol. 286:40–48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zatelli MC, Piccin D, Tagliati F, Bottoni
A, Luchin A, Vignali C, Margutti A, Bondanelli M, Pansini GC and
Pelizzo MR: Selective activation of somatostatin receptor subtypes
differentially modulates secretion and viability in human medullary
thyroid carcinoma primary cultures: Potential clinical
perspectives. J Clin Endocrinol Metab. 91:2218–2224. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ruscica M, Magni P, Steffani L, Gatto F,
Albertelli M, Rametta R, Valenti L, Ameri P, Magnaghi V and Culler
MD: Characterization and sub-cellular localization of SS1R, SS2R,
and SS5R in human late-stage prostate cancer cells: Effect of mono-
and bi-specific somatostatin analogs on cell growth. Mol Cell
Endocrinol. 382:860–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Theodoropoulou M and Stalla GK:
Somatostatin receptors: From signaling to clinical practice. Front
Neuroendocrinol. 34:228–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
War SA and Kumar U: Coexpression of human
somatostatin receptor-2 (SSTR2) and SSTR3 modulates
antiproliferative signaling and apoptosis. J Mol Signal. 7:1–15.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rocheville M, Lange DC, Kumar U, Sasi R,
Patel RC and Patel YC: Subtypes of the somatostatin receptor
assemble as functional homo- and heterodimers. J Biol Chem.
275:7862–7869. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Missiaglia E, Dalai I, Barbi S, Beghelli
S, Falconi M, Della PM, Piemonti L, Capurso G, Di FA and Delle FG:
Pancreatic endocrine tumors: Expression profiling evidences a role
for AKT-mTOR pathway. J Clin Oncol. 28:245–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vikić-Topić S, Raisch KP, Kvols LK and
Vuk-Pavlović S: Expression of somatostatin receptor subtypes in
breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin
Endocrinol Metab. 80:2974–2979. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Skanberg J, Ahlman H, Benjegard SA,
Fjalling M, Forssell Aronsson EB, Hashemi SH, Nilsson O, Suurkula M
and Jansson S: Indium-111-octreotide scintigraphy, intraoperative
gamma-detector localisation and somatostatin receptor expression in
primary human breast cancer. Breast Cancer Res Treat. 74:101–111.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cakir M, Dworakowska D and Grossman A:
Somatostatin receptor biology in neuroendocrine and pituitary
tumours: Part 1-molecular pathways. J Cell Mol Med. 14:2585–2591.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Callison JC Jr, Walker RC and Massion PP:
Somatostatin receptors in lung cancer: From function to molecular
imaging and therapeutics. J Lung Cancer. 10:69–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watt HL, Kharmate G and Kumar U: Biology
of somatostatin in breast cancer. Mol Cell Endocrinol. 286:251–261.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hicks RJ: Use of molecular targeted agents
for the diagnosis, staging and therapy of neuroendocrine
malignancy. Cancer Imaging 10 Spec no A. S83–S91. 2010. View Article : Google Scholar
|
|
16
|
Reubi JC, Schaer JC, Waser B and Mengod G:
Expression and localization of somatostatin receptor SSTR1, SSTR2,
and SSTR3 messenger RNAs in primary human tumors using in Situ
Hybridization. Cancer Res. 54:3455–3459. 1994.PubMed/NCBI
|
|
17
|
Schmid HA, Lambertini C, Van Vugt HH,
Barzaghi-Rinaudo P, Schäfer J, Hillenbrand R, Sailer AW, Kaufmann M
and Nuciforo P: Monoclonal antibodies against the human
somatostatin receptor subtypes 1-5: Development and
immunohistochemical application in neuroendocrine tumors.
Neuroendocrinology. 95:232–247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hofland LJ and Lamberts SW: Somatostatin
receptors and disease: Role of receptor subtypes. Baillières Clin
Endocrinol Metab. 10:163–176. 1996. View Article : Google Scholar
|
|
19
|
Wang S, Bao Z, Liang QM, Long JW, Xiao ZS,
Jiang ZJ, Liu B, Yang J and Long ZX: Octreotide stimulates
somatostatin receptor-induced apoptosis of SW480 colon cancer cells
by activation of glycogen synthase kinase-3beta, A Wnt/beta-catenin
pathway modulator. Hepatogastroenterology. 60:1639–1646.
2013.PubMed/NCBI
|
|
20
|
Grant M, Alturaihi H, Jaquet P, Collier B
and Kumar U: Cell growth inhibition and functioning of human
somatostatin receptor type 2 are modulated by receptor
heterodimerization. Mol Endocrinol. 22:2278–2292. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hasskarl J, Kaufmann M and Schmid HA:
Somatostatin receptors in non-neuroendocrine malignancies: The
potential role of somatostatin analogs in solid tumors. Future
Oncol. 7:895–913. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Raderer M, Hejna MH, Muller C, Kornek GV,
Kurtaran A, Virgolini I, Fiebieger W, Hamilton G and Scheithauer W:
Treatment of hepatocellular cancer with the long acting
somatostatin analog lanreotide in vitro in vivo. Int J
Oncol. 16:1197–1201. 2000.PubMed/NCBI
|
|
23
|
Li M, Zhang R, Li F, Wang H, Kim HJ,
Becnel L, Yao Q, Chen C and Fisher WE: Transfection of SSTR-1 and
SSTR-2 Inhibits Panc-1 Cell proliferation and renders Panc-1 cells
responsive to somatostatin analogue. J Am Coll Surg. 201:571–578.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arena S, Barbieri F, Thellung S, Pirani P,
Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti
JL, et al: Expression of somatostatin receptor mRNA in human
meningiomas and their implication in in vitro antiproliferative
activity. J Neurooncol. 66:155–166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barbieri F, Pattarozzi A, Gatti M, Aiello
C, Quintero A, Lunardi G, Bajetto A, Ferrari A, Culler MD and
Florio T: Differential efficacy of SSTR1, −2, and −5 agonists in
the inhibition of C6 glioma growth in nude mice. Am J Physiol
Endocrinol Metab. 297:1078–1088. 2009. View Article : Google Scholar
|
|
26
|
Xu Y, Song J, Berelowitz M and Bruno JF:
Estrogen regulates somatostatin receptor subtype 2 messenger
ribonucleic acid expression in human breast cancer cells.
Endocrinology. 137:5634–5640. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Patel YC: Somatostatin and its receptor
family. Front Neuroendocrinol. 20:157–198. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bonifacino JS, Gershlick DC and
Dell'Angelica EC: Immunoprecipitation. Curr Protoc Cell Biol.
1:712016.
|
|
29
|
Bansal C, Singh US, Misra S, Sharma KL,
Tiwari V and Srivastava AN: Comparative evaluation of the modified
Scarff-Bloom-Richardson grading system on breast carcinoma
aspirates and histopathology. Cytojournal. 9:42012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mohamed A, Romano D, Saveanu A, Roche C,
Albertelli M, Barbieri F, Brue T, Niccoli P, Delpero JR, Garcia S,
et al: Anti-proliferative and anti-secretory effects of everolimus
on human pancreatic neuroendocrine tumors primary cultures: Is
there any benefit from combination with somatostatin analogs?
Oncotarget. 8:41044–41063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kumar U, Grigorakis SI, Watt HL, Sasi R,
Snell L, Watson P and Chaudhari S: Somatostatin receptors in
primary human breast cancer: Quantitative analysis of mRNA for
subtypes 1-5 and correlation with receptor protein expression and
tumor pathology. Breast Cancer Res Treat. 92:175–186. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rivera JA, Alturaihi H and Kumar U:
Differential regulation of somatostatin receptors 1 and 2 mRNA and
protein expression by tamoxifen and estradiol in breast cancer
cells. J Carcinog. 4:102005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishioka H, Tamura K, Iida H, Kutsukake M,
Endo A, Ikeda Y and Haraoka J: Co-expression of somatostatin
receptor subtypes and estrogen receptor-α mRNAs by non-functioning
pituitary adenomas in young patients. Mol Cell Endocrinol.
331:73–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frati A, Rouzier R, Lesieur B, Werkoff G,
Antoine M, Rodenas A, Darai E and Chereau E: Expression of
somatostatin type-2 and −4 receptor and correlation with
histological type in breast cancer. Anticancer Res. 34:3997–4003.
2014.PubMed/NCBI
|
|
35
|
Rae JM, Creighton CJ, Meck JM, Haddad BR
and Johnson MD: MDA-MB-435 cells are derived from M14 melanoma
cells-a loss for breast cancer, but a boon for melanoma research.
Breast Cancer Res Treat. 104:13–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang W, Qiao Y and Li Z: New insights into
modes of GPCR activation. Trends in Pharmacol Sci. 39:367–386.
2018. View Article : Google Scholar
|
|
37
|
Somvanshi RK, War SA, Chaudhari N, Qiu X
and Kumar U: Receptor specific crosstalk and modulation of
signaling upon heterodimerization between β1-adrenergic receptor
and somatostatin receptor-5. Cell Signal. 23:794–811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Watt HL, Kharmate GD and Kumar U:
Somatostatin receptors 1 and 5 heterodimerize with epidermal growth
factor receptor: Agonist-dependent modulation of the downstream
MAPK signalling pathway in breast cancer cells. Cell Signal.
21:428–439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Watt HL and Kumar U: Colocalization of
somatostatin receptors and epidermal growth factor receptors in
breast cancer cells. Cancer Cell Int. 6:1–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
